HEADER HYDROLASE 20-DEC-19 6TS6
TITLE COAGULATION FACTOR XI PROTEASE DOMAIN IN COMPLEX WITH ACTIVE SITE
TITLE 2 INHIBITOR
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: COAGULATION FACTOR XI;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: FXI,PLASMA THROMBOPLASTIN ANTECEDENT,PTA;
COMPND 5 EC: 3.4.21.27;
COMPND 6 ENGINEERED: YES;
COMPND 7 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: F11;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS S1 PROTEASE, SERINE PROTEASE, STRUCTURE-BASED DRUG DESIGN, ACTIVE
KEYWDS 2 SITE DIRECTED INHIBITOR, HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR M.RENATUS,N.SCHIERING
REVDAT 3 13-NOV-24 6TS6 1 REMARK
REVDAT 2 26-AUG-20 6TS6 1 JRNL
REVDAT 1 08-JUL-20 6TS6 0
JRNL AUTH E.LORTHIOIS,J.ROACHE,D.BARNES-SEEMAN,E.ALTMANN,U.HASSIEPEN,
JRNL AUTH 2 G.TURNER,R.DUVADIE,V.HORNAK,R.G.KARKI,N.SCHIERING,
JRNL AUTH 3 W.A.WEIHOFEN,F.PERRUCCIO,A.CALHOUN,T.FAZAL,D.DEDIC,C.DURAND,
JRNL AUTH 4 S.DUSSAUGE,K.FETTIS,F.TRITSCH,C.DENTEL,A.DRUET,D.LIU,
JRNL AUTH 5 L.KIRMAN,J.LACHAL,K.NAMOTO,D.BEVAN,R.MO,G.MONNET,L.MULLER,
JRNL AUTH 6 R.ZESSIS,X.HUANG,L.LINDSLEY,T.CURRIE,Y.H.CHIU,C.FRIDRICH,
JRNL AUTH 7 P.DELGADO,S.WANG,M.HOLLIS-SYMYNKYWICZ,J.BERGHAUSEN,
JRNL AUTH 8 E.WILLIAMS,H.LIU,G.LIANG,H.KIM,P.HOFFMANN,A.HEIN,P.RAMAGE,
JRNL AUTH 9 A.D'ARCY,S.HARLFINGER,M.RENATUS,S.RUEDISSER,D.FELDMAN,
JRNL AUTH10 J.ELLIOTT,R.SEDRANI,J.MAIBAUM,C.M.ADAMS
JRNL TITL STRUCTURE-BASED DESIGN AND PRECLINICAL CHARACTERIZATION OF
JRNL TITL 2 SELECTIVE AND ORALLY BIOAVAILABLE FACTOR XIA INHIBITORS:
JRNL TITL 3 DEMONSTRATING THE POWER OF AN INTEGRATED S1 PROTEASE FAMILY
JRNL TITL 4 APPROACH.
JRNL REF J.MED.CHEM. V. 63 8088 2020
JRNL REFN ISSN 0022-2623
JRNL PMID 32551603
JRNL DOI 10.1021/ACS.JMEDCHEM.0C00279
REMARK 2
REMARK 2 RESOLUTION. 1.33 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.7
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.33
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7
REMARK 3 NUMBER OF REFLECTIONS : 55874
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.194
REMARK 3 R VALUE (WORKING SET) : 0.193
REMARK 3 FREE R VALUE : 0.210
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : 2701
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.33
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.36
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.23
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL
REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : 0.2022
REMARK 3 BIN FREE R VALUE : 0.2154
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 56
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 1875
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 60
REMARK 3 SOLVENT ATOMS : 224
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 19.66
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.81
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 1.86610
REMARK 3 B22 (A**2) : -4.63230
REMARK 3 B33 (A**2) : 2.76620
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.170
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.058
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.058
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.056
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.056
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.925
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 2030 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 2766 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 701 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL
REMARK 3 GENERAL PLANES : 342 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 2030 ; 10.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 258 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 2016 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.008
REMARK 3 BOND ANGLES (DEGREES) : 1.02
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.54
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 13.77
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 1
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: { A|* }
REMARK 3 ORIGIN FOR THE GROUP (A): 24.7396 -2.2266 -3.5682
REMARK 3 T TENSOR
REMARK 3 T11: -0.0268 T22: -0.0402
REMARK 3 T33: -0.0312 T12: -0.004
REMARK 3 T13: 0.009 T23: 0.0044
REMARK 3 L TENSOR
REMARK 3 L11: 0.6841 L22: 0.693
REMARK 3 L33: 0.48 L12: -0.3294
REMARK 3 L13: 0.0342 L23: 0.0078
REMARK 3 S TENSOR
REMARK 3 S11: 0.0009 S12: 0.0089 S13: -0.0442
REMARK 3 S21: 0.0089 S22: 0.021 S23: 0.0272
REMARK 3 S31: -0.0442 S32: 0.0272 S33: -0.0219
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 6TS6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-DEC-19.
REMARK 100 THE DEPOSITION ID IS D_1292105984.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 14-APR-15
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SLS
REMARK 200 BEAMLINE : X10SA
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.000040
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL
REMARK 200 DATA SCALING SOFTWARE : XSCALE JANUARY 30, 2009
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55884
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.330
REMARK 200 RESOLUTION RANGE LOW (A) : 60.070
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7
REMARK 200 DATA REDUNDANCY : 4.883
REMARK 200 R MERGE (I) : 0.13400
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.0900
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.33
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.36
REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5
REMARK 200 DATA REDUNDANCY IN SHELL : 4.74
REMARK 200 R MERGE FOR SHELL (I) : 0.48500
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.090
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: NULL
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 45.60
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM SULFATE, 0.1 M BIS-TRIS
REMARK 280 PH5.5, 25% W/V POLYETHYLENE GLYCOL 3350, VAPOR DIFFUSION,
REMARK 280 SITTING DROP, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.03000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 33.29500
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.36500
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 33.29500
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.03000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 30.36500
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1020 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 11670 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 ALA A 244
REMARK 465 VAL A 245
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LYS A 95 -60.86 -128.53
REMARK 500 SER A 214 -61.73 -127.92
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 301
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 302
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 303
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 304
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 305
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 306
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue NW5 A 307
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 6TS4 RELATED DB: PDB
REMARK 900 RELATED ID: 6TS5 RELATED DB: PDB
REMARK 900 RELATED ID: 6T7P RELATED DB: PDB
DBREF 6TS6 A 16 245 UNP P03951 FA11_HUMAN 388 625
SEQADV 6TS6 SER A 123 UNP P03951 CYS 500 ENGINEERED MUTATION
SEQRES 1 A 238 ILE VAL GLY GLY THR ALA SER VAL ARG GLY GLU TRP PRO
SEQRES 2 A 238 TRP GLN VAL THR LEU HIS THR THR SER PRO THR GLN ARG
SEQRES 3 A 238 HIS LEU CYS GLY GLY SER ILE ILE GLY ASN GLN TRP ILE
SEQRES 4 A 238 LEU THR ALA ALA HIS CYS PHE TYR GLY VAL GLU SER PRO
SEQRES 5 A 238 LYS ILE LEU ARG VAL TYR SER GLY ILE LEU ASN GLN SER
SEQRES 6 A 238 GLU ILE LYS GLU ASP THR SER PHE PHE GLY VAL GLN GLU
SEQRES 7 A 238 ILE ILE ILE HIS ASP GLN TYR LYS MET ALA GLU SER GLY
SEQRES 8 A 238 TYR ASP ILE ALA LEU LEU LYS LEU GLU THR THR VAL ASN
SEQRES 9 A 238 TYR THR ASP SER GLN ARG PRO ILE SER LEU PRO SER LYS
SEQRES 10 A 238 GLY ASP ARG ASN VAL ILE TYR THR ASP CYS TRP VAL THR
SEQRES 11 A 238 GLY TRP GLY TYR ARG LYS LEU ARG ASP LYS ILE GLN ASN
SEQRES 12 A 238 THR LEU GLN LYS ALA LYS ILE PRO LEU VAL THR ASN GLU
SEQRES 13 A 238 GLU CYS GLN LYS ARG TYR ARG GLY HIS LYS ILE THR HIS
SEQRES 14 A 238 LYS MET ILE CYS ALA GLY TYR ARG GLU GLY GLY LYS ASP
SEQRES 15 A 238 ALA CYS LYS GLY ASP SER GLY GLY PRO LEU SER CYS LYS
SEQRES 16 A 238 HIS ASN GLU VAL TRP HIS LEU VAL GLY ILE THR SER TRP
SEQRES 17 A 238 GLY GLU GLY CYS ALA GLN ARG GLU ARG PRO GLY VAL TYR
SEQRES 18 A 238 THR ASN VAL VAL GLU TYR VAL ASP TRP ILE LEU GLU LYS
SEQRES 19 A 238 THR GLN ALA VAL
HET SO4 A 301 5
HET SO4 A 302 5
HET SO4 A 303 5
HET DMS A 304 4
HET DMS A 305 4
HET DMS A 306 4
HET NW5 A 307 33
HETNAM SO4 SULFATE ION
HETNAM DMS DIMETHYL SULFOXIDE
HETNAM NW5 2-[2-[[3-[(3~{S})-3-AZANYL-2,3-DIHYDRO-1-BENZOFURAN-5-
HETNAM 2 NW5 YL]-5-(2-CYANOPROPAN-2-YL)
HETNAM 3 NW5 PHENYL]METHOXY]PHENYL]ETHANOIC ACID
FORMUL 2 SO4 3(O4 S 2-)
FORMUL 5 DMS 3(C2 H6 O S)
FORMUL 8 NW5 C27 H26 N2 O4
FORMUL 9 HOH *224(H2 O)
HELIX 1 AA1 ALA A 55 TYR A 59A 5 6
HELIX 2 AA2 SER A 61 LYS A 63 5 3
HELIX 3 AA3 ASN A 73 ILE A 77 5 5
HELIX 4 AA4 MET A 96 GLY A 100 5 5
HELIX 5 AA5 THR A 164 TYR A 172 1 9
HELIX 6 AA6 TYR A 234 GLN A 243 1 10
SHEET 1 AA1 8 THR A 20 ALA A 21 0
SHEET 2 AA1 8 GLN A 156 LYS A 159 -1 O LYS A 157 N THR A 20
SHEET 3 AA1 8 CYS A 136 GLY A 140 -1 N VAL A 138 O ALA A 158
SHEET 4 AA1 8 PRO A 198 HIS A 202A-1 O SER A 198B N TRP A 137
SHEET 5 AA1 8 VAL A 202D TRP A 215 -1 O VAL A 202D N HIS A 202A
SHEET 6 AA1 8 GLY A 226 ASN A 230 -1 O VAL A 227 N TRP A 215
SHEET 7 AA1 8 MET A 180 ALA A 183 -1 N ILE A 181 O TYR A 228
SHEET 8 AA1 8 LEU A 162 VAL A 163 -1 N VAL A 163 O CYS A 182
SHEET 1 AA2 7 GLN A 30 THR A 35 0
SHEET 2 AA2 7 ARG A 37D GLY A 46 -1 O LEU A 39 N LEU A 33
SHEET 3 AA2 7 TRP A 51 THR A 54 -1 O LEU A 53 N SER A 43
SHEET 4 AA2 7 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54
SHEET 5 AA2 7 PHE A 83 ILE A 90 -1 N ILE A 89 O LEU A 105
SHEET 6 AA2 7 LEU A 65 TYR A 68 -1 N VAL A 67 O PHE A 83
SHEET 7 AA2 7 GLN A 30 THR A 35 -1 N HIS A 34 O ARG A 66
SSBOND 1 CYS A 40 CYS A 58 1555 1555 2.04
SSBOND 2 CYS A 136 CYS A 201 1555 1555 2.06
SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.02
SSBOND 4 CYS A 191 CYS A 219 1555 1555 2.06
CISPEP 1 SER A 37 PRO A 37A 0 3.77
SITE 1 AC1 6 THR A 177 HIS A 178 HOH A 420 HOH A 446
SITE 2 AC1 6 HOH A 466 HOH A 517
SITE 1 AC2 9 GLN A 93 TYR A 101 ASP A 135 TRP A 137
SITE 2 AC2 9 LYS A 179 LYS A 202 HOH A 401 HOH A 406
SITE 3 AC2 9 HOH A 586
SITE 1 AC3 7 LYS A 127 GLY A 128 ASP A 129 ARG A 130
SITE 2 AC3 7 HOH A 435 HOH A 464 HOH A 469
SITE 1 AC4 6 TYR A 133 LEU A 162 ILE A 181 ASN A 230
SITE 2 AC4 6 HOH A 418 HOH A 485
SITE 1 AC5 4 HIS A 202A ASN A 202B HOH A 505 HOH A 549
SITE 1 AC6 5 THR A 164 ASN A 165 GLU A 166 HIS A 178
SITE 2 AC6 5 HOH A 522
SITE 1 AC7 15 HIS A 57 ASP A 189 ALA A 190 CYS A 191
SITE 2 AC7 15 LYS A 192 GLY A 193 ASP A 194 SER A 195
SITE 3 AC7 15 THR A 213 TRP A 215 GLY A 216 GLY A 218
SITE 4 AC7 15 CYS A 219 HOH A 571 HOH A 572
CRYST1 60.060 60.730 66.590 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.016650 0.000000 0.000000 0.00000
SCALE2 0.000000 0.016466 0.000000 0.00000
SCALE3 0.000000 0.000000 0.015017 0.00000